GGrantIndex
← Search

OPEN-LABEL, DOSE ESCALATION PHASE 1 STUDY TO EVAL CLOSTRODIUM DIFFICILE TOXIN A

$967M01FY2005RRNIH

Tufts Medical Center, Boston MA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →